# Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/regression-rates-following-the-treatment-of-aggressive-posterior-retinopathy-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | S Nicoară,Anne Claudia Ştefănuţ,C Nascutzy,Gabriela Zaharie,Laura Emilia Toader,Tudor Drugan |
| Citations | 38 |
| DOI | 10.12659/msm.897095 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://medscimonit.com/download/index/idArt/897095 |
| OpenAlex ID | https://openalex.org/W2338565477 |
| PMID | 27062023 |
| Type | article |
| Year | 2016 |

## Paper authors

- [S Nicoară](https://scholariq.org/researchers/s-nicoara/)

## Paper journal

- [Medical Science Monitor](https://scholariq.org/journals/medical-science-monitor/)

## Paper primary topic

- [Retinopathy of Prematurity Studies](https://scholariq.org/topics/retinopathy-of-prematurity-studies/)

## Paper topics

- [Retinopathy of Prematurity Studies](https://scholariq.org/topics/retinopathy-of-prematurity-studies/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Neonatal Health and Biochemistry](https://scholariq.org/topics/neonatal-health-and-biochemistry/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.